It is a pharma private limited company based in New Delhi, Delhi, India, established in 2000.
2000 | New Delhi, Delhi, India | ActiveOshino Drugs Private Limited, a active private limited company, was established on 17 February 2000 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239DL2000PTC103818. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.92 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Savita Rani (Additional Director), Vishal Gupta (Director). Past directors included Rajesh Kumar Verma, Payal Gupta. It holds ₹1.22 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at C-240, Flat No. 107, 1St Floor Pandav Nagar, New Delhi, Delhi, 110092.
U24239DL2000PTC103818
103818
17 February 2000
₹2.00 M
₹1.92 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Oshino Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Savita Rani | Additional Director | 07 Jan 2010 | Current |
| Vishal Gupta | Director | 01 Oct 2005 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2007 | Past |
| Pramod Abcsdd | Director | 07 Jan 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Oshino Drugs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.65% increase. The company also saw a substantial improvement in profitability, with a 11.37% increase in profit. The company's net worth Soared by an impressive increase of 44.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Oshino Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹12,197,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2024 | Canara Bank | ₹2.63 M | Open |
| 15 Sep 2018 | Canara Bank | ₹1.00 M | Open |
| 31 Jan 2014 | Canara Bank | ₹0.57 M | Open |
| 24 Sep 2010 | Others | ₹8.00 M | Open |
Explore comprehensive loan charge details -
Oshino Drugs has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Oshino Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oshino Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Oshino Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on A charge with Canara Bank amounted to Rs. 2.63 M with Charge ID 100932764 was registered on 18 May 2024. was documented.
Progress on Oshino Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Others of Rs. 8.00 M registered on 24 Sep 2010 with Charge ID 10244272 was modified on 22 Dec 2021. was recorded as a recent event.
A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100208785 was registered on 15 Sep 2018. was recorded as a recent event.
Progress on A charge with Canara Bank amounted to Rs. 0.57 M with Charge ID 10496010 was registered on 31 Jan 2014. was documented.
The CIN of Oshino Drugs Private Limited is U24239DL2000PTC103818.
Oshino Drugs Private Limited is headquartered at C-240, Flat No. 107, 1St Floor Pandav Nagar, New Delhi, Delhi, 110092.
Oshino Drugs Private Limited was incorporated on 17 February 2000.
The current directors of Oshino Drugs Private Limited are
The primary industry of Oshino Drugs Private Limited is Manufacturing.
Oshino Drugs Private Limited is unlisted.
The authorized capital of Oshino Drugs Private Limited is ₹2.00 M, and the paid-up capital is ₹1.92 M.
The compliance status of Oshino Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX